Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
MIRA Pharmaceuticals Inc. (NASDAQ : MIRA ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Quote
| Last: | $1.023 |
|---|---|
| Change Percent: | -2.37% |
| Open: | $1.02 |
| Close: | $1.0478 |
| High: | $1.035 |
| Low: | $1.0006 |
| Volume: | 31,689 |
| Last Trade Date Time: | 03/30/2026 12:06:21 pm |
Stock Data
| Market Cap: | $50,670,065 |
|---|---|
| Float: | 35,670,051 |
| Insiders Ownership: | 8.48% |
| Institutions: | 7 |
| Short Percent: | N/A |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Website: | https://mirapharmaceuticals.com |
| Country: | US |
| City: | Miami |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about MIRA Pharmaceuticals Inc. (NASDAQ: MIRA).
